Boston Scientific Announces Results For Third Quarter 2021 :

Boston Scientific Announces Results For Third Quarter 2021

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.932 billion during the third quarter of 2021, growing 10.3 percent on a...

Related Keywords

Japan , Malaysia , Taiwan , Philippines , United States , Brazil , China , Vietnam , Republic Of , Boston , Massachusetts , Czech Republic , South Africa , Colombia , Indonesia , Canada , Russia , Mexico , India , Thailand , Saudi Arabia , Chile , South Korea , Poland , Turkey , America , Japanese , Lauren Tengler , Mike Mahoney , Kate Haranis , Boston Scientific Corporation , Baylis Medical Company Inc , Us Centers For Medicare , A New Technology Payment , Japanese Pharmaceuticals , Medicaid Services , Heart Rhythm Society Annual Meeting , Boston Scientific , Preventice Solutions Inc , Pelvic Health , Specialty Pharmaceuticals , Exchange Commission , Prnewswire Boston Scientific Corporation , Us Food Drug Administration , Devoro Medical Inc , Securities Exchange , Farapulse Inc , Devices Agency , European Society For Medical Oncology , Scientific Corporation , Middle East , Medical Company , Medical Inc , Drug Administration , Modelb Single Use Bronchoscope , New Technology Add On Payment , Modeld Single Use Duodenoscope , Endovascular System , Drug Eluting Vascular Stent System , Drug Coated Balloon , European Society , Medical Oncology , Clinical Oncology , Heart Rhythm , Heart Rhythm Society , Annual Meeting , Left Atrial Appendage Closure Devices , Medical Devices Agency , Cryoablation System , Emerging Markets , Medical Surgical , Medical Devices , Medical Device , Full Year , Fourth Quarter , Preventice Solutions , Statement Regarding Forward Looking Statements , Securities Act , Securities Exchange Act , Risk Factors , Annual Report , Quarterly Reports , Months Ended September , Mandatory Convertible Preferred Stock , Before Income , Financial Accounting Standards Board , Accounting Standards Codification , Estimated Annual Effective Tax Rate , Financial Condition , Quarterly Report ,

© 2025 Vimarsana